DANIELLE RUCCI: Open Payments
NPI 1417680638 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 31 payments from 12 companies in 2025. Trend: 2023 $212 · 2024 $456 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $152 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Pharming Healthcare, Inc. | 3 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $62 |
| United Therapeutics Corporation | 2 | $59 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Baxter Healthcare | 1 | $30 |
| CSL Behring | 1 | $26 |
| Ionis Pharmaceuticals, Inc. | 1 | $26 |
Products named: TRELEGY ELLIPTA, RUCONEST, CUVITRU, AIRSUPRA, Tyvaso, OFEV, TEZSPIRE, Hillrom - Vest System Model 105 Home Care.
Industry payments across CA — which companies pay providers there.
